Senior insider sale
President and CEO at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$638.2K
100K shares
What this filing means
LOWENTHAL RICHARD E plans to sell 100K shares of ARS PHARMACEUTICALS, INC. valued at approximately $638.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2026ACC: 0001950047-26-008376
DirectorOfficer10% Owner· President and CEO
Since Nov 2022
100K
Shares to sell
$638.2K
Approx. market value
50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/19/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/19/2026 | Stock Option Exercise Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
50K
Market value
$315.9K
8/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$322.3K
8/19/2026
Total
Units
100K
Value
$638.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2026 | 50K | $315.9K | — | Completed |
| Planned — Approximate Date | ||||
8/19/2026 | 50K | $322.3K | NASDAQ | Planned |
| Total | 100K | $638.2K | ||